GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
+47.19%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$383M
AUM Growth
+$383M
Cap. Flow
-$56.4M
Cap. Flow %
-14.72%
Top 10 Hldgs %
72.58%
Holding
52
New
10
Increased
7
Reduced
6
Closed
17

Top Buys

1
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$23.1M
2
AVXS
AveXis, Inc. Common Stock
AVXS
$15.7M
3
MACK
Merrimack Pharmaceuticals, Inc.
MACK
$15.5M
4
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
$15.3M
5
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
$8.08M

Top Sells

1
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$31.1M
2
EXEL icon
Exelixis
EXEL
$25M
3
BLUE
bluebird bio
BLUE
$21.6M
4
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
$21.3M
5
XNCR icon
Xencor
XNCR
$8.55M

Sector Composition

1 Healthcare 79.04%
2 Technology 2.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VNDA icon
1
Vanda Pharmaceuticals
VNDA
$279M
$45M 11.49% 2,706,134 +376 +0% +$6.26K
ADMS
2
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$42.7M 10.89% 2,601,351 +492,252 +23% +$8.08M
SGYP
3
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$35.4M 9.03% 6,422,232 -1,167,768 -15% -$6.43M
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
$27.9M 7.12% 2,440,959 – –
FOMX
5
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$25.6M 6.54% 2,769,425 +2,494,669 +908% +$23.1M
DERM
6
DELISTED
Dermira, Inc.
DERM
$23M 5.86% 679,403 -120,597 -15% -$4.08M
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
$21.9M 5.58% 3,475,227 +236,524 +7% +$1.49M
ENTA icon
8
Enanta Pharmaceuticals
ENTA
$180M
$21M 5.36% 790,000 +251,976 +47% +$6.71M
NBIX icon
9
Neurocrine Biosciences
NBIX
$13.8B
$20M 5.09% 394,080 -75,920 -16% -$3.84M
AVXS
10
DELISTED
AveXis, Inc. Common Stock
AVXS
$15.7M 4.01% +381,095 New +$15.7M
MACK
11
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$15.5M 3.96% +2,442,159 New +$15.5M
CLCD
12
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$15.3M 3.89% +400,000 New +$15.3M
APYX icon
13
Apyx Medical
APYX
$75.3M
$14M 3.56% 2,680,000 – –
SAGE
14
DELISTED
Sage Therapeutics
SAGE
$12.2M 3.11% 264,893 -65,107 -20% -$3M
CNXR
15
DELISTED
Connecture, Inc.
CNXR
$7.76M 1.98% 4,127,232 – –
ARDM
16
DELISTED
Aradigm Corp Common Stock
ARDM
$6.9M 1.76% 1,002,962 – –
OCRX
17
DELISTED
Ocera Therapeutics, Inc.
OCRX
$5.18M 1.32% 1,963,777 – –
DBVT
18
DBV Technologies
DBVT
$264M
$4.78M 1.22% +131,452 New +$4.78M
VIRX
19
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.65M 1.19% 1,063,573 -7,110,364 -87% -$31.1M
ALIM
20
DELISTED
Alimera Sciences, Inc.
ALIM
$3.93M 1% +2,637,969 New +$3.93M
PLXP
21
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$2.59M 0.66% 178,930 +91,016 +104% +$1.32M
TENX icon
22
Tenax Therapeutics
TENX
$27.3M
$2.57M 0.66% 1,108,593 – –
PDLI
23
DELISTED
PDL BioPharma, Inc.
PDLI
$2.16M 0.55% +645,000 New +$2.16M
TTPH
24
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.73M 0.44% 452,375 -1,847,154 -80% -$7.08M
ATXS icon
25
Astria Therapeutics
ATXS
$349M
$1.54M 0.39% +250,000 New +$1.54M
1
2 3